Home|Journals|Articles by Year|Audio Abstracts

Original Research

AAM. 2012; 1(3): 77-86

Randomized Clinical Trial of Kshar Vasti in the Management of Amavata (Rheumatoid Arthritis)



1. Objective: To evaluate the efficacy of Kshar Vasti in Amavata w.s.r. Rheumatoid Arthritis. Methodology: Total 66 patients were randomly divided into two groups having 33 patients in each group. In group I (Kshar Vasti) 29 patients and Group II (Control group) 28 patients completed all the three follow ups. Result: In Group I good improvement (62.0%)), moderate improvement (20.7%), and unchanged or none (17.2%) was observed. In Group II good improvement (28.6%), moderate improvement (53.6%), and unchanged or none (17.8%) was observed. Conclusion: In this study Kshar Vasti is comparable to Tab. Nucoxia -90. Both the groups showed significant relief in joints and muscular pain but Kshar Vasti group showed better improvement in most of symptoms.

Key words: Amavata, Rheumatoid Arthritis, Agni, Ama, Kshar Vasti and Visual Analog Scale.

Full-text options

Share this Article

Online Article Submission
• ejmanager.com

ejPort - eJManager.com
Refer & Earn
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.